Plus Therapeutics
Price & Volume
Stats
See moreOpen | $1.59 |
Previous Close | $1.47 |
Day Range | $1.47-$1.74 |
52W Range | $0.24-$2.67 |
Market Cap | $8.6M |
Shares Short | 59,847 |
Financials
See moreRevenue (12 Mos) | $5.7M |
Revenue Growth (YoY) | 17.4% |
Gross Profit (12 Mos) | -$5.4M |
Diluted EPS | -$2.44 |
News
See moreYahoo Finance • 7 days ago
Why Plus Therapeutics Inc. (PSTV) Surged On Thursday?
Yahoo Finance • 8 days ago
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
Yahoo Finance • 9 days ago
Plus Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 27, 2025
Yahoo Finance • 18 days ago
Plus Therapeutics Regains Compliance with Nasdaq Minimum Stockholders’ Equity Requirement
About
CEO | Dr. Marc H. Hedrick M.B.A., M.D. |
CFO | Mr. Andrew J. Sims CPA |
Address | 4200 Marathon Boulevard, Austin, TX, United States, 78756 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 20 |
